Clinical Trials Browser

Active not recruiting × Prostatic Neoplasms × Congresses as Topic × Clear all

NCT01444820 2024-12-04

Hypofractionated, Dose Escalation Radiotherapy for High Risk Adenocarcinoma of the Prostate

Phase 3 Active not recruiting

Prostatic Neoplasms